Sodium valproate is contraindicated in POLG-related diseases because of liver failure risk
In POLG-related mitochondrial diseases, account for the contraindication to sodium valproate because of hepatocellular failure risk. Management involves symptom-directed care and prevention of complications.
#sodium valproate d8miq7k9f04rm.cloudfront.net